Completed
Benzonatate Dose Tolerance Study
NCT01690975
- Conditions
- Cough, Pathological Conditions, Signs and Symptoms, Respiration Disorders, +3 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States